NYSE$UHT

Universal Health Realty Income Trust · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Reported a decrease in net income due to increased interest expense and demolition expenses, partially offset by increased income from various properties.

Universal Health Realty Income Trust reported a net income of $3.5 million, or $0.25 per diluted share, for the second quarter of 2023, compared to $5.2 million, or $0.38 per diluted share, in the same period of 2022. The decrease was primarily due to higher interest expense and demolition costs related to a property in Chicago.

  • Net income decreased by $1.7 million, or $0.13 per diluted share, compared to Q2 2022.
  • Increased interest expense due to higher borrowing rates and outstanding borrowings negatively impacted net income by $1.8 million, or $0.13 per diluted share.
  • Demolition expenses in Chicago reduced net income by $862,000, or $0.06 per diluted share.
  • Funds from operations (FFO) decreased to $10.6 million, or $0.77 per diluted share, from $12.2 million, or $0.88 per diluted share, in Q2 2022.

Headline financials

Total Revenue

$23.8M

Previous: $22.2M+7.4%
EPS (adj)

$0.25

Previous: $0.38-34.2%
Dividend Paid Per Share

$0.72

No prior period
Available Borrowing Capacity

$60.5M

No prior period
Capital Expenditures

-$13.6M

Previous: -$13.6M+0.0%
Free Cash Flow

-$10.1M

Previous: -$8.4M-20.7%
Net Income

$3.48M

Previous: $5.22M-33.4%
Operating Income

$7.38M

Previous: $7.24M+2.0%
Gross Profit

$23.8M

Previous: $22.2M+7.4%
Cash & Equivalents

$9.46M

Previous: $8.4M+12.6%
Total Assets

$603M

Previous: $604M-0.1%
Stock-Based Comp

$188K

Previous: $208K-9.6%

Revenue & EPS history

UHT · Revenue · Quarterly

$23.8M

Q2 2023+7.4%vs Q2 2022

Revenue by segment

UHT · $537K total across 2 segments · Q2 2023

  • Other Revenue - Non-related parties
    $292K+20.7%
  • Other Revenue - UHS Facilities
    $245K+5.2%

Forward guidance

The press release contains forward-looking statements based on current management expectations. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants’ employees and patients; and potential increases to other expenditures. In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

Headwinds

  • Decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the nationwide shortage of nurses and other clinical staff and support personnel
  • The impact of government and administrative regulation of the health care industry
  • Declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs)
  • Potential disruptions related to supplies required for our tenants’ employees and patients
  • Potential increases to other expenditures
  • The increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-0.0%

Avg return

Earnings day

-0.2%

Avg return

5 days after

+1.0%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+12.7%

Q1 2020

Best reaction

-6.8%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.9%-0.8%
Q4 2025+0.2%-0.7%-9.7%
Q3 2025+2.1%+4.9%+12.7%
Q1 2025-0.5%+1.7%+2.2%
Q4 2024+0.8%+1.9%+3.0%
Q3 2024-2.9%-4.6%-2.2%
Q2 2024+2.5%+1.6%+5.1%
Q1 2024+0.8%+5.8%+10.1%
Q4 2023+0.2%-4.1%-9.7%
Q3 2023+1.1%-0.9%+3.4%
Q2 2023-3.4%-3.7%-5.2%
Q1 2023-5.9%-6.5%-8.3%
Q4 2022-1.5%-5.8%-11.9%
Q3 2022+5.3%+8.8%+15.6%
Q2 2022+2.3%+2.8%-0.1%
Q1 2022-3.1%-11.1%-7.3%
Q4 2021+1.2%+4.2%+3.4%
Q3 2021+0.5%-0.6%+2.2%
Q2 2021-0.7%-1.8%-3.7%
Q1 2021+0.2%-3.0%-0.0%
Q4 2020-6.1%-6.3%+7.8%
Q3 2020-2.3%+2.7%+14.5%
Q2 2020+0.7%+3.2%-0.1%
Q1 2020+12.7%+9.9%+5.9%
Q4 2019-6.6%-8.1%-21.6%
Q3 2019+3.7%+8.4%+0.7%
Q2 2019+1.6%+3.2%+5.6%
Q1 2019+3.8%+3.7%+8.0%
Q4 2018+0.3%+0.2%+1.1%
Q3 2018-6.8%-11.2%-6.2%
Q2 2018+0.8%+4.4%+15.6%
Q1 2018+4.1%+2.0%+3.1%
Q4 2017+3.0%+6.4%+8.6%
Q3 2017-0.8%-2.9%-0.2%
Q2 2017-5.6%-6.7%-10.0%
Q1 2017+0.3%+0.9%+3.0%
Q4 2016-0.1%-1.3%+0.5%
Q3 2016-4.1%-5.8%-0.3%
Q2 2016-1.1%+0.7%+3.5%
Q1 2016-1.5%
Q4 2015+0.6%
Q3 2015-0.1%
Q2 2015+0.7%
Q1 2015-2.3%
Q4 2014-0.7%
Q3 2014+1.4%
Q2 2014-1.1%
Q1 2014-0.2%
Q4 2013+1.6%
Q3 2013+1.9%
Q2 2013-0.5%
Q1 2013-1.9%
Q1 2011-0.2%
Q4 2012+1.7%
Q3 2012-1.7%
Q4 2011-1.0%
Q2 2012-1.0%
Q1 2012+0.6%
Q4 2009-1.2%
Q3 2010+0.0%
Q3 2011+0.0%
Q2 2011+0.3%
Q4 2010+0.3%
Q2 2010+0.3%
Q1 2010+4.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro